is an infrequent, but serious event that complicates coronary interventions. Our aim was to analyse clinical predictors of rVF in an unselected population of STEMI patients treated with percutaneous coronary intervention (PCI). Consecutive STEMI patients admitted to a tertiary care hospital for primary PCI during 2007-2012 were retrospectively assessed for the presence of rVF. Admission ECG stored in a digital format, were analysed for a maximal ST elevation in a single lead (maxST) and a sum of ST-deviations in all leads (sumST). Clinical, ECG and angiographic characteristics were tested for association with rVF using logistic regression analysis. Among 3724 STEMI patients admitted during 2007-2012, 71 (1.9%) suffered from rVF. In univariate analysis, history of myocardial infarction (MI), aspirin and beta-blocker use, VF before PCI, left main coronary artery disease, inferior MI localization, symptom-to-balloon time less than 360 minutes, maxST greater than 300 µV and sumST > 1500 µV were associated with increased risk of rVF. In a multivariate analysis, sumST > 1500 µV (OR 3.7; p=0.006, 95%CI 1.45-9.41) before PCI remained independent predictor of rVF. In-hospital mortality was 18.3% in rVF group vs. 3.3% in NoVF group (p<0.001), however rVF was not an independent predictor of in-hospital death. In conclusion, the magnitude of ST-elevation before PCI for STEMI independently predicts rVF and should be considered in periprocedural arrhythmic risk assessment. Despite higher in-hospital mortality in rVF patients, reperfusional VF itself has no independent prognostic value for prognosis.
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Ventricular fibrillation (VF) during reperfusion for ST-elevation myocardial infarction (STEMI) is an infrequent event, however it complicates coronary interventions and subsequent hospital stay (1). Because of its relatively low incidence, the predictors and prognostic value of VF at reperfusion are usually analysed together with other VF episodes at any time of acute STEMI (2) (3) (4) . Some studies divided VF on early and late (2, 5) , some of them dealt with prereperfusion (6), periprocedural (1) or postprocedural (7) VF. While experimental studies have been searching for specific underlying mechanisms of reperfusional arrhythmias on cellular level, clinical studies focused on VF at reperfusion for STEMI in unselected populations, to the best of our knowledge, are lacking. Most clinical studies analysed clinical and angiographic predictors of VF, whereas the data on dynamic electrocardiographic changes that can predict VF, especially VF at reperfusion, are scarce. Our aim was to analyse electrocardiographic (ECG) characteristics associated with VF during reperfusion in unselected STEMI patients treated with percutaneous coronary intervention (PCI).
Methods.
Consecutive STEMI patients admitted to Lund University Hospital for primary PCI during 2007-2012 were retrospectively assessed for the presence of VF during reperfusion. The information about cardiopulmonary resuscitation or defibrillation for VF was retrieved from the Swedish National Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA) and information about reperfusion arrhythmias was obtained from Swedish Coronary Angiography and Angioplasty Register (SCAAR). Then medical histories of patients were reviewed to crosscheck VF occurrence and its timing in relation to infarct-related artery (IRA) opening. Relevant clinical information was taken from the RIKS-HIA Register, angiographic characteristics were determined from the SCAAR Register.
ECG stored in digital format either in GE Marquette MUSE system (GE Medical Systems, Milwaukee, Wisconsin) or Infinity MegaCare ECG Management System (Dräger, Lübeck, Germany) databases were analysed for predictors of VF during reperfusion. We looked for admission ECG and a historical ECG recorded prior coronary event.
A previously recorded standard 12-lead ECG unrelated to STEMI available for interpretation was defined as historical ECG. Most recent ECG was used for analysis if several historical ECGs were available. Apart from the standard criteria (P, PR, QRS, QT, QTc intervals, presence of right or left bundle branch block (RBBB/LBBB)), the presence of J-point elevation at least 1mm above baseline in two contiguous either inferior or lateral leads was analysed.
An ECG recorded after onset of STEMI, but prior to coronary intervention was defined as admission ECG. If several ECGs were recorded prior to PCI, the latest ECG was considered as admission ECG -either in-hospital or pre-hospital ECG (in those cases when in-hospital ECG prior to PCI was not taken or not saved in the database). The ECGs with paced rhythm were excluded. ECGs with complete RBBB/LBBB were excluded from analysis of parameters characterizing ventricular repolarization (i.e. ST-level, QT, QTc). On the base of admission ECG, the maximal ST elevation in a single lead with most prominent elevation (STmax), the sum of ST-deviations in all 12 leads (sumST), including ST-elevation and reciprocal depression, as well as Anderson-Wilkins and Sclarowsky-Birnbaum scores were calculated.
In brief, the Anderson-Wilkins acuteness score (8) takes into consideration the presence of abnormal Q-waves to the Selvester QRS scoring system (9) and the morphology of T-wave, classified as tall, positive, flat or negative. The acuteness of each standard lead with ST-elevation is classified from no points to 4 points, then the total sum in all leads is divided by the number of leads involved to correct for the overall extent of the myocardial involvement. To identify clinical factors associated with VF at reperfusion, relevant clinical, angiographic and electrocardiographic factors were compared across groups using chi-square or Fisher's exact test for categorical variables and Student's t -test for continuous variables with an approximate normal distribution, or Man-Whitney U-test, as appropriate. Significantly associated covariates were further evaluated in univariate logistic regression models with estimation of odds ratios and likelihood-ratio tests. To determine independent factors of risk, factors significantly associated with reperfusional VF in univariate models were included in a stepwise regression analysis with backwards elimination. p -values <0.05 were considered significant. All analyses were performed using SPSS 22.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Among 3274 STEMI patients admitted for primary PCI during 2007-2012, 71 (1.9%) suffered from VF during reperfusion. The incidence of reperfusion VF did not differ in different Patients with VF at reperfusion were more likely to have a history of myocardial infarction and more often used beta-blockers and aspirin than those without VF ( Table 1) . Patients with VF at reperfusion more often suffered from VF before PCI, either out of hospital, during ambulance transport or in hospital prior to the balloon inflation. 11 patients from 71 in rVF group had VF both before and during reperfusion, whereas 60 patients had no VF before reperfusion and suffered from reperfusion VF only. There were no differences between the groups in regard to age, gender, smoking, presence of hypertension, diabetes, anamnesis of stroke, history of congestive heart failure, using digitalis at admission, proportion of patients with Killip class >1, and serum creatinine at admission. The level of potassium at admission was significantly lower in rVF group, though within normal range. Patients with VF at reperfusion had shorter symptomto-balloon time, more often had inferior localization of myocardial infarction and left main stenosis on angiography. The percentage of multivessel disease and IRA distribution did not differ between groups.
The patients suffered from VF at reperfusion were more likely to have longer QRS interval on historical ECG before event ( Table 2) . Only one patient from rVF group had J-point elevation in lateral leads meeting criteria for early repolarization on historical ECG. The patients with VF at reperfusion had higher ST elevation before PCI, but did not differ in either Anderson-Wilkins acuteness score or Sclarovsky-Birnbaum score comparing with No rVF group. The percentage of LBBB/RBBB and conventional ECG-criteria did not differ between groups.
In a univariate regression analysis, the following factors were associated with increased risk of VF during reperfusion: history of myocardial infarction, aspirin and beta-blockers use, VF before PCI, potassium level at admission, left main coronary artery disease, inferior localization of MI, duration of QRS on historical ECG, symptom-to-balloon time less than 360 minutes, STelevation in a single lead greater than 300 µV and sum of ST-deviations in all leads greater than 1500 µV. (Table 3 ). In a multivariate analysis, sum of ST-deviations in all leads greater than 7 VF during reperfusion.
Since pre-reperfusional VF appeared to be a strong predictor of rVF, we also performed a separate analysis of the predictors of lone rVF in patients who did not suffer from VF before IRA opening ( Table 4 ). In the univariate regression analysis, the following factors were associated with increased risk of lone VF during reperfusion: history of myocardial infarction, aspirin and beta-blocker use, hypopotassiemia at admission, left main coronary artery disease, duration of QRS on historical ECG, symptom-to-balloon time less than 360 minutes, ST-elevation in single lead greater than 300 µV and sum of ST-deviations in all leads greater than 1500 µV. In a multivariate analysis, sum of ST-deviations in all leads greater than 1500 µV, aspirin use and QRS duration on historical ECG remained independent predictor of lone VF during reperfusion.
In-hospital mortality in whole rVF group was 18.3%. In-hospital mortality in patients with lone VF at reperfusion was found to be 16.7% comparing with 3.3% in patients with no VF before and during reperfusion (p<0.001 for both comparisons). In the univariate analysis, age, history of myocardial infarction, Killip class>1 at admission, VF before reperfusion, VF during reperfusion, left main stenosis and multivessel disease were associated with increased in-hospital mortality ( Table 5 ). In the multivariate analysis, age, heart failure at admission, VF before reperfusion and left main stenosis were independent predictors of poor in-hospital prognosis.
However, reperfusion VF was not an independent predictor of in-hospital mortality.
Discussion
The occurrence of VF at reperfusion in our study (1.5-2.1% in different years) is lower compared with previously reported incidence of periprocedural VF in STEMI. In APEX AMI enrolled 5745 STEMI patients, periprocedural VT/VF occurred in 180 patients -3.1% (11). In PAMI, included 3065 patients, 133 of them (4.3%) suffered from VT/VF in cardiac catheterization laboratory (1). These differences can be explained by several factors, that distinguish our study from abovementioned. First, we took into consideration only VF and VT demanding defibrillation, not all sustained VT and VF as in (1, 4, 11) . Secondly, we consider only VF occurring after IRA opening, not all periprocedural VF as in (1). Then, these studies included STEMI patients admitted within 6 (11) or 12 (1) hours from symptom onset, and APEX AMI included high-risk STEMI only, whereas our study analysed an unselected STEMI cohort.
In our previous study we showed that reperfusional VF accounted for 22% of VF occurring during the first 48 hours of STEMI treated by primary PCI (3).
The occurrence of VF at reperfusion in our study was higher in inferior STEMI localization. This is in line with previously published data concerning VF in STEMI, but not directly related to reperfusion (11-13). The higher incidence of VF in inferior STEMI, especially with right ventricular involvement can be explained by much more prominent I to in epicardium of the right ventricle than the left one (14) . We also observed a tendency to the prevalence of RCA as IRA that previously had been reported to be predictive for VF (1). Notably, in our cohort, patients with inferior STEMI having higher risk of rVF had lower max ST elevation than patients with anterior STEMI (309±219 vs 501±339 µV, p<0.001).
In earlier studies, TIMI 0 before PCI has been reported to be predictive for VF in catheterization laboratory (1). In our study all 71 patients who suffered from rVF had total acute coronary occlusions, while there were no cases of non-occlusive stenoses in this group. The rate of thrombectomy in VF group was 53% comparing to 12% in No VF group (p<0.001).
We have not found any association of VF at reperfusion with multivessel disease, which is in accordance with the APEX-AMI trial, concerning VF not directly related to reperfusion (11).
The patients with reperfusion VF were more likely to have left main stenosis, which could lead to more intensive ischemia and larger area of myocardium at risk involved into ischemiareperfusion. We believe that the higher rate of beta-blocker and aspirin treatment in VF group should be considered as a more sensitive indicator of underlying cardiovascular comorbidities than anamnestic information.
Hypokalemia is known to be a predictor of VF during STEMI, especially in regard to VF occurring shortly after symptom onset (15) . We analysed the association of the potassium level at admission and reperfusion VF, and found that despite the differences between rVF group and No rVF group, the average potassium level was normal in both groups. The percentage of patients with hypokalaemia at admission tended to be higher in rVF group (5.8% vs 2.7%), but the difference has not reached statistical significance. The symptom-PCI time was shorter in rVF group, in agreement with PAMI trial results (1). VF before PCI was predictive for VF during reperfusion, reflecting interindividual variation in vulnerability to ventricular arrhythmias in the settings of ischemia-reperfusion. At the same time, 85% of patients who suffered from VF during reperfusion had experienced no VF before reperfusion.
In earlier studies, the sum ST deviation at ECG was predictive for VF at any time of STEMI (11), but did not influence the occurrence of postprocedural VF (7) . We found that the magnitude of ST-elevation, reflecting ischemia intensity before primary PCI, predicts VF during reperfusion. Since myocardial ischemia affects not only ventricular repolarization but also depolarization process, we scrutinized admission ECGs for Sclarovsky-Birnbaum ischemia grades. The terminal distortion of QRS-complex corresponding to grade 3 of ischemia is believed to reflect severe and prolonged ischemia that affects Purkinje fibres (10) and correlates to larger infarct size and less myocardial salvage at reperfusion (16, 17) . In our study, the percentage of patients with Birnbaum 3 ischemia grade on admission did not differ between groups despite the shorter symptom to PCI time in rVF group. We believe that it might be explained by the presence of patients with fast progression myocardial infarction due to poor collateral flow or absence of preconditioning in the rVF group (10).
We reviewed not only admission ECGs, but also historical ECG before STEMI. We demonstrated that QRS duration before the coronary event is a predictor of VF during reperfusion for subsequent STEMI. This finding is in agreement with results of Tikkanen (18) on longer QRS duration in future victims of sudden death during acute coronary event.
Recently, a number of studies reported the association between J-wave pattern on historical ECG and life-threating ventricular arrhythmias and sudden death during acute ischemic event (18) (19) (20) (21) . The association of a initially existing J-wave pattern with future arrhythmic complications during acute STEMI was explained by the presence of heterogeneity of ventricular repolarization as a substrate predisposing to the development of ventricular arrhythmias in the setting of an acute ischemia trigger (22) . In our study J-wave point elevation was observed in 0,2%, that is much lower than in the above mentioned studies -11-16% (18, 19) , and than the reported early repolarization (ER) prevalence in general population -4.5% (23) . However, ER is known to be an age-dependant phenomenon, and in age group 60-70 years, corresponding the average age at the moment of historical ECG in our study, its prevalence appears to be in the range of 1.5% in women and 2-3% in man (23) thus being in line with our observations.
In-hospital mortality in rVF group was five times as high as in No rVF group as earlier reported by others (2, 6, 24) . The majority of cases of in-hospital death in both rVF and No rVF groups were due to heart failure, among other causes were mechanical complications, cerebral injury and reinfarction, that is in accordance with a literature (1). Despite markedly increased inhospital mortality in rVF group in our study, reperfusion VF has not been found to have an independent prognostic value for in-hospital mortality.
Because of the low prevalence of reperfusion VF in PCI-treated STEMI we have chosen to compare the unselected cohort of patients admitted with STEMI during 2007 with all those who had reperfusion VF during 2007-2012, which may affect interpretation of our findings since standards of care might have been modified over the six-year period. However, invasive strategy as the first-choice approach in STEMI has been adopted long before 2007, the annual incidence of reperfusion VF and symptoms-to-balloon time remained similar during study period thus suggesting that this would affect study findings in a limited extent.
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